Literature DB >> 2680380

Neoantigens associated with halothane hepatitis.

L R Pohl1, J G Kenna, H Satoh, D Christ, J L Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2680380     DOI： 10.3109/03602538909103537

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  16 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 2.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 3.  Drug-induced "allergic hepatitis".

Authors:  P Podevin; M Biour
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

4.  Generation of T cell responses targeting the reactive metabolite of halothane in mice.

Authors:  Qiang You; Linling Cheng; Cynthia Ju
Journal:  Toxicol Lett       Date:  2010-02-13       Impact factor: 4.372

Review 5.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a review.

Authors:  Dolores B Njoku
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-05       Impact factor: 4.481

6.  Trifluoroacetylated IgG4 antibodies in a child with idiosyncratic acute liver failure after first exposure to halothane.

Authors:  Christine Nguyen; Noel R Rose; Dolores B Njoku
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-08       Impact factor: 2.839

7.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury.

Authors:  Dolores B Njoku; Zhaoxia Li; Nicole D Washington; Jenelle L Mellerson; Monica V Talor; Rajni Sharma; Noel R Rose
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

8.  Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.

Authors:  Imir G Metushi; Corron Sanders; William M Lee; Jack Uetrecht
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

Review 9.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

10.  Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.

Authors:  J W Harris; L R Pohl; J L Martin; M W Anders
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.